These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25663986)

  • 21. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder.
    Vakili Y; Gharaee B; Habibi M
    Iran J Psychiatry Behav Sci; 2015 Jun; 9(2):e845. PubMed ID: 26288647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder.
    Zhou DD; Wang W; Wang GM; Li DQ; Kuang L
    J Affect Disord; 2017 Jun; 215():187-196. PubMed ID: 28340445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there potential for repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment of OCD?
    Zaman R; Robbins TW
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):672-678. PubMed ID: 28953851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of deep repetitive transcranial magnetic stimulation over the medial prefrontal cortex in obsessive compulsive disorder: results from an open-label study.
    Modirrousta M; Shams E; Katz C; Mansouri B; Moussavi Z; Sareen J; Enns M
    Depress Anxiety; 2015 Jun; 32(6):445-50. PubMed ID: 25826717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder.
    Bloch MH; McGuire J; Landeros-Weisenberger A; Leckman JF; Pittenger C
    Mol Psychiatry; 2010 Aug; 15(8):850-5. PubMed ID: 19468281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder.
    Martin JL; Barbanoj MJ; Pérez V; Sacristán M
    Cochrane Database Syst Rev; 2003; 2003(3):CD003387. PubMed ID: 12917964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.
    Bandelow B; Allgulander C; Baldwin DS; Costa DLDC; Denys D; Dilbaz N; Domschke K; Hollander E; Kasper S; Möller HJ; Eriksson E; Fineberg NA; Hättenschwiler J; Kaiya H; Karavaeva T; Katzman MA; Kim YK; Inoue T; Lim L; Masdrakis V; Menchón JM; Miguel EC; Nardi AE; Pallanti S; Perna G; Rujescu D; Starcevic V; Stein DJ; Tsai SJ; Van Ameringen M; Vasileva A; Wang Z; Zohar J
    World J Biol Psychiatry; 2023 Feb; 24(2):118-134. PubMed ID: 35900217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review.
    Jaafari N; Rachid F; Rotge JY; Polosan M; El-Hage W; Belin D; Vibert N; Pelissolo A
    World J Biol Psychiatry; 2012 Mar; 13(3):164-77. PubMed ID: 21623668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials.
    Chen JJ; Liu Z; Zhu D; Li Q; Zhang H; Huang H; Wei Y; Mu J; Yang D; Xie P
    Psychiatry Res; 2014 Sep; 219(1):51-7. PubMed ID: 24889845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transcranial magnetic stimulation in obsessive compulsive disorder: a systematic review].
    Euser AM; Stapert AF; Oosterhoff M; van Balkom IDC; Figee M
    Tijdschr Psychiatr; 2017; 59(10):617-625. PubMed ID: 29077137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial Magnetic Stimulation of the Supplementary Motor Area in the Treatment of Obsessive-Compulsive Disorder: A Multi-Site Study.
    Hawken ER; Dilkov D; Kaludiev E; Simek S; Zhang F; Milev R
    Int J Mol Sci; 2016 Mar; 17(3):420. PubMed ID: 27011177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Thatikonda NS; Vinod P; Balachander S; Bhaskarpillai B; Arumugham SS; Reddy YCJ
    Can J Psychiatry; 2023 Jun; 68(6):407-417. PubMed ID: 35989677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New treatment options for OCD.
    Fineberg NA
    Int J Psychiatry Clin Pract; 2007; 11 Suppl 2():24-30. PubMed ID: 24926869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial.
    Mowla A; Khajeian AM; Sahraian A; Chohedri AH; Kashkoli F
    CNS Spectr; 2010 Nov; 15(11):613-7. PubMed ID: 24726048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials.
    Suhas S; Malo PK; Kumar V; Issac TG; Chithra NK; Bhaskarapillai B; Reddy YCJ; Rao NP
    World J Biol Psychiatry; 2023 Feb; 24(2):162-177. PubMed ID: 35615998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation at Orbitofrontal Cortex in the Treatment of Patients With Medication-Refractory Obsessive-Compulsive Disorder: A Retrospective Open Study.
    Kumar S; Singh S; Chadda RK; Verma R; Kumar N
    J ECT; 2018 Jun; 34(2):e16-e19. PubMed ID: 29053484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder.
    Shahini N; Talaei A; Shalbafan M; Faridhosseini F; Ziaee M
    Basic Clin Neurosci; 2021; 12(4):489-498. PubMed ID: 35154589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis.
    Fitzsimmons SMDD; van der Werf YD; van Campen AD; Arns M; Sack AT; Hoogendoorn AW; ; van den Heuvel OA
    J Affect Disord; 2022 Apr; 302():302-312. PubMed ID: 35041869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder.
    Modarresi A; Chaibakhsh S; Koulaeinejad N; Koupaei SR
    Psychiatry Res; 2019 Dec; 282():112602. PubMed ID: 31630042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
    Xia J; Du Y; Han J; Liu G; Wang X
    Drug Des Devel Ther; 2015; 9():2101-17. PubMed ID: 25960632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.